SCM
IMVT icon

Sio Capital Management’s Immunovant IMVT Stock Holding History

Sio Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-152,450
Closed -$3.71M – 93
2020
Q2 		$3.71M Buy
152,450
+38,317
+34% +$821K 1.08% 35
2020
Q1 		$1.78M Sell
114,133
-501,267
-81% -$7.54M 0.6% 37
2019
Q4 		$5.48M Buy
+615,400
New +$6.89M 1.31% 23

Other funds holding IMVT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Sio Capital Management's IMVT Position: Q3 2020 in Review

Sio Capital Management sold out of Immunovant (IMVT) in Q3 2020, closing a stake of 152,450 shares — an estimated $3.71M sold.

Sio Capital Management first reported a position in IMVT in Q4 2019 and held it in 3 quarters. The position peaked at $5.48M in Q4 2019. 115 funds tracked by Wall St. Rank hold IMVT as of Q3 2020.

  • Sio Capital Management reported no remaining Immunovant position as of Q3 2020 after selling out during the quarter.
  • Sio Capital Management sold 152,450 Immunovant shares in Q3 2020, an estimated $3.71M.
  • Sio Capital Management first reported a position in Immunovant in Q4 2019 and held it in 3 quarters.
  • Sio Capital Management's Immunovant position peaked at $5.48M in Q4 2019.
  • 115 funds tracked by Wall St. Rank held Immunovant as of Q3 2020.

Based on Sio Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.